AUGUST 4, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced its presentation of a poster explaining the Company’s use of flow cytometry for diagnosis of lung disease including cancer at the International Society for Advancement of Cytometry CYTO 2020 to be held virtually on August 4-5, 2020. “We are pleased […]
Dr. Lydia Bederka will present the poster “Sputum-Derived Cellular Profiles Produced by Flow Cytometric Analysis” (Poster #P223) at the International Society for the Advancement of Cytometry conference, CYTO2020 on August 4-5, 2020. Cytometry is the quantitative analysis of cells and cell systems and is used in the analysis of sputum for the diagnosis of lung cancer. […]
State of the Industry is February 11th, 2020 at the Grand Hyatt in San Antonio, TX. The premier annual event celebrating the people of San Antonio’s healthcare and bioscience industry conveys five stories in the effort to advance human health. Maria Zannes will speak about what drives motivation, innovation, and success. The Health Cell “State of […]
7th Annual UTSA Innovation Awards Tuesday, November 12, 2019 6 p.m. Reception | 7 p.m. Dinner Eilan Hotel — Incanto Ballroom 18603 La Cantera Terrace San Antonio, TX 78256 Keynote: Maria Zannes, CEO of BioAffinity Techonlogies Inc. The annual UTSA Innovation Awards recognize Innovation Excellence in the UTSA research community. These annual awards will be […]
OCTOBER 11, 2019 (San Antonio, TX) bioAffinity Technologies, a privately-held biotech company, today announced that it has been accepted as a member of the American Cancer Society’s National Lung Cancer Roundtable (NLCRT), a collaborative whose membership is focused on reducing both the incidence of lung cancer and mortality rates from the disease. “We are honored […]
bioAffinity Technologies proudly will present at Advancing Early Lung Cancer Detection at the Cleveland Clinic, an invitation-only symposium that brings together clinical experts, advocacy groups and industry leaders working to advance new technologies and methods necessary to find lung cancer at its earliest stages. September 26 and 27, 2019 Cleveland, Ohio The Advancing Early Lung […]